-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CTpiwisYhR81mY2BjBmd6Zc781ffZuBa+bL/5jtzHf01uhGIw0MeOTtcHMvXcW8i oXI99veqmtmkH4WBLveODg== 0001116679-05-002189.txt : 20050826 0001116679-05-002189.hdr.sgml : 20050826 20050826115443 ACCESSION NUMBER: 0001116679-05-002189 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050826 DATE AS OF CHANGE: 20050826 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIOENVISION INC CENTRAL INDEX KEY: 0001028205 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113375915 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-31787 FILM NUMBER: 051050806 BUSINESS ADDRESS: STREET 1: 345 PARK AVENUE STREET 2: 41ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 212-750-6700 MAIL ADDRESS: STREET 1: 345 PARK AVENUE STREET 2: 41ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: ASCOT GROUP INC DATE OF NAME CHANGE: 19961205 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: WOOD CHRISTOPHER B CENTRAL INDEX KEY: 0001099455 RELATIONSHIP: OTHER FILING VALUES: FORM TYPE: 144 BUSINESS ADDRESS: BUSINESS PHONE: 011441718397570 MAIL ADDRESS: STREET 1: THE CEDARS HOLLYBRUSH HILL STOKE POGES STREET 2: BUCKS UK SL2 AQN 144 1 fm144.txt - ------------------------------------------------------------------------------------------------------------------------------------ | | OMB APPROVAL | | |--------------------------------| | |OMB Number: 3235-0101| | |--------------------------------| | |Expires: December 31, 2006| | UNITED STATES |--------------------------------| | SECURITIES AND EXCHANGE COMMISSION |Estimated average burden | | Washington, D.C. 20549 |hours per response...........2.0| | ---------------------------------| | FORM 144 ---------------------------------| | | SEC USE ONLY | | NOTICE OF PROPOSED SALE OF SECURITIES |--------------------------------| | PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 |DOCUMENT SEQUENCE NO. | | |--------------------------------| | ATTENTION: Transmit for filing 3 copies of this form concurrently |CUSIP NUMBER | | with either placing an order with a broker to execute sale or |--------------------------------| | executing a sale directly with a market maker |WORK LOCATION | | ---------------------------------| | | |----------------------------------------------------------------------------------------------------------------------------------| | 1(a) NAME OF ISSUER (Please type or print): (b) IRS IDENT. NO.: (c) S.E.C. FILE NO.: | | | | Bioenvision, Inc. 13-4025875 001-31787 | | | |----------------------------------------------------------------------------------------------------------------------------------| | 1(d) ADDRESS OF ISSUER ( STREET, CITY, STATE, ZIP CODE): (e) TELEPHONE | | ---------------------------------------------------| |345 Park Avenue, 41st Floor, New York, NY 10154 AREA CODE: 212 NUMBERS: 750-6700 | |----------------------------------------------------------------------------------------------------------------------------------| | 2(a) NAME OF PERSON FOR WHOSE ACCOUNT (b) IRS IDENT. (c) RELATIONSHIP TO (d) ADDRESS (STREET, CITY, STATE, ZIP CODE): | | THE SECURITIES ARE TO BE SOLD: NO.: ISSUER: | | | | Christopher B. Wood Officer/Director 345 Park Avenue, 41st Floor, New York, NY 10154| | | | | |----------------------------------------------------------------------------------------------------------------------------------| | INSTRUCTION: The person filing this notice should contact the issuer to obtain the | | I.R.S. identification Number and the S.E.C. File Number. | |----------------------------------------------------------------------------------------------------------------------------------| | (b) Name and | | Address of Each SEC USE ONLY (g) Name | | Broker Through whom (c) Number (e) Number of Each | | the Securities Are ------------ of Shares or of Shares or (f) Approx- Securities| | To Be Offered or Broker- Other Units (d) Agggregate Other Units imate Date Exchange | |3(a) Title of the Each Market Maker Dealer To Be Sold Market Value Outstanding of Sale (See (See | |Class of Securities who Is Acquiring File Number (See instr. (See instr. (See instr. instr. 3(f)) instr. | |To Be Sold the Securities 3(c)) 3(d)) 3(e)) (MO. DAY YR.) 3(g)) | |----------------------------------------------------------------------------------------------------------------------------------| | | | Common Stock Smith Barney 15,000 $131,250 40,569,567 August 29, 2005 Nasdaq | | 388 Greenwich Street | | New York, NY 10013 | | | | | |----------------------------------------------------------------------------------------------------------------------------------| | | | | | | |----------------------------------------------------------------------------------------------------------------------------------| | | | | | | |----------------------------------------------------------------------------------------------------------------------------------| | | | INSTRUCTIONS: | | | | 1. (a) Name of issuer | | (b) Issuer's I.R.S. Identification Number | | (c) Issuer's S.E.C. file number, if any | | (d) Issuer's address, including zip code | | (e) Issuers's telephone number, including area code | | | | 2. (a) Name of person for whose account the securities are to be sold | | (b) Such person's I.R.S. identification number, if such person is an entity | | (c) Such person's relationship to the issuer (e.g., officer, director, 10% stockholder, or member of immediate family of | | any of the foregoing) | | (d) Such person's address, including zip code | | | | 3. (a) Title of the class of securities to be sold | | (b) Name and Address of each broker through whom the securities are intended to be sold | | (c) Number of shares or other units to be sold (if debt securities, give the aggregate face amount) | | (d) Aggregate market value of the securities to be sold as of a specified date within 10 days prior to the filing of this | | notice | | (e) Number of shares or other units of the class outstanding, or if debt securities the face amount thereof outstanding, as | | shown by the most recent report or statement published by the issuer | | (f) Approximate date on which the securities are to be sold | | (g) Name of each securities exchange, if any, on which the securities are intended to be sold | | | - ------------------------------------------------------------------------------------------------------------------------------------
|----------------------------------------------------------------------------------------------------------------------------------| | TABLE I --SECURITIES TO BE SOLD | | Furnish the following information with respect to the acquisition of the securities to be sold | | and with respect to the payment of all or any part of the purchase price or other consideration therefor: | |----------------------------------------------------------------------------------------------------------------------------------| | Name of Person | | from Whom Acquired | | (if gift, also | | Date you Nature of Acquisition give date donor Amount of Securities Date of Nature of | | Title of the Class Acquired Transaction acquired) Acquired Payment Payment | |----------------------------------------------------------------------------------------------------------------------------------| | | |Common Stock 2/4/00 compensation for Bioenvision, Inc. 100,000 2/4/00 services | | services rendered | | as co-founder. | | | | | |----------------------------------------------------------------------------------------------------------------------------------| | | | | | | | | |----------------------------------------------------------------------------------------------------------------------------------| | | | | | | | | |----------------------------------------------------------------------------------------------------------------------------------| | | | INSTRUCTIONS: | | | | 1. If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the | | table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other | | obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was | | discharged in full or the last installment paid. | | | | 2. If within two years after the acquisition of the securities the person for whose account they are to be sold had any short | | positions, put or other option to dispose of securities referred to in paragraph (d)(3) of Rule 144, furnish full | | information with respect thereto. | | | | | |----------------------------------------------------------------------------------------------------------------------------------| | TABLE II -- SECURITIES SOLD DURING THE PAST 3 MONTHS | | Furnish the following information as to all securities of the issuer sold | | during the past 3 months by the person for whose account the securities are to be sold. | |----------------------------------------------------------------------------------------------------------------------------------| | Date of | | Name and Address of Seller Title of Securities Sold Sale Amount of Securities Sold Gross Proceeds | |----------------------------------------------------------------------------------------------------------------------------------| | | | Christopher Wood, 345 Park Ave. Common Stock July 8, 2005 5,000 $38,643.37 | | 41st Floor, New York, NY 10154 | | | | | | | |----------------------------------------------------------------------------------------------------------------------------------| | | | | | REMARKS: | | | | | | | | | | | | | | | | INSTRUCTIONS: ATTENTION: | | | | See the definition of "person" in paragraph (a) of Rule 144. The person for whose account the securities to which this notice | | Information is to be given not only as to the person for whose relates are to be sold hereby represents by signing this notice | | account the securities are to be sold but also as to all other that he does not know any material adverse information in regard | | persons included in that definition. In addition, information to the current and prospective operations of the Issuer of the | | shall be given as to sales by all persons whose sales are securities to be sold which has not been publicly disclosed. | | required by paragraph (e) of Rule 144 to be aggregated with | | sales for the account of the person filing this notice. | | | | | | July 21, 2005 /s/ Christopher B. Wood | | ------------------------------------------- ------------------------------------------ | | DATE OF NOTICE (SIGNATURE) | | | | The notice shall be signed by the person for whose account the securities are to be sold. At least one copy of the notice shall | | be manually signed. Any copies not manually signed shall bear typed or printed signatures | | | - ------------------------------------------------------------------------------------------------------------------------------------ 2
-----END PRIVACY-ENHANCED MESSAGE-----